These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18384628)

  • 41. L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer.
    Sakata T; Ferdous G; Tsuruta T; Satoh T; Baba S; Muto T; Ueno A; Kanai Y; Endou H; Okayasu I
    Pathol Int; 2009 Jan; 59(1):7-18. PubMed ID: 19121087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.
    Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y
    Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
    Lin WC; Hu FC; Chung SD; Chueh SC; Pu YS; Huang KH
    J Urol; 2008 Sep; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor risk assessment by means of immunocytochemical detection of early pre-malignant changes in buccal smears.
    Bloching MM; Soulsby H; Naumann A; Aust W; Merkel D; Braun T; Naim R
    Oncol Rep; 2008 Jun; 19(6):1373-9. PubMed ID: 18497939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors in a prospective series of papillary renal cell carcinoma.
    Gontero P; Ceratti G; Guglielmetti S; Andorno A; Terrone C; Bonvini D; Faggiano F; Tizzani A; Frea B; Valente G
    BJU Int; 2008 Sep; 102(6):697-702. PubMed ID: 18489525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
    Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
    J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
    Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
    Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sporadic upper urinary tract urothelial cell carcinomas: identification of interaction between toxic carcinogens and individuals genetic susceptibility].
    Colin P; Koenig P; Ballereau C; Phé V; Berthon N; Villers A; Biserte J; Rouprêt M
    Prog Urol; 2010 Jan; 20(1):1-10. PubMed ID: 20123521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma.
    Simone G; Papalia R; Loreto A; Leonardo C; Sentinelli S; Gallucci M
    BJU Int; 2009 Apr; 103(8):1052-7. PubMed ID: 18990140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.
    Sung MT; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R; Wang M; Tan PH; Cheng L
    Clin Cancer Res; 2008 Apr; 14(7):1947-55. PubMed ID: 18381932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.
    Zlobec I; Baker K; Terracciano LM; Lugli A
    Clin Cancer Res; 2008 Jun; 14(12):3798-806. PubMed ID: 18559599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct mitotic segregation errors mediate chromosomal instability in aggressive urothelial cancers.
    Jin Y; Stewénius Y; Lindgren D; Frigyesi A; Calcagnile O; Jonson T; Edqvist A; Larsson N; Lundberg LM; Chebil G; Liedberg F; Gudjonsson S; Månsson W; Höglund M; Gisselsson D
    Clin Cancer Res; 2007 Mar; 13(6):1703-12. PubMed ID: 17363523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression.
    Simiantonaki N; Taxeidis M; Jayasinghe C; Kurzik-Dumke U; Kirkpatrick CJ
    BMC Cancer; 2008 Nov; 8():320. PubMed ID: 18983642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
    Remzi M; Haitel A; Margulis V; Karakiewicz P; Montorsi F; Kikuchi E; Zigeuner R; Weizer A; Bolenz C; Bensalah K; Suardi N; Raman JD; Lotan Y; Waldert M; Ng CK; Fernández M; Koppie TM; Ströbel P; Kabbani W; Murai M; Langner C; Roscigno M; Wheat J; Guo CC; Wood CG; Shariat SF
    BJU Int; 2009 Feb; 103(3):307-11. PubMed ID: 18990163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic and predictive factors in colorectal cancer.
    Zlobec I; Lugli A
    J Clin Pathol; 2008 May; 61(5):561-9. PubMed ID: 18326017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer.
    Arentsen HC; de la Rosette JJ; de Reijke TM; Langbein S
    Expert Rev Mol Diagn; 2007 Jan; 7(1):11-9. PubMed ID: 17187480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging.
    Painter DJ; Timoney AG; Denton K; Alken P; Keeley FX
    BJU Int; 2007 May; 99(5):973-7. PubMed ID: 17437428
    [No Abstract]   [Full Text] [Related]  

  • 59. Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.
    Catto JW; Hartmann A; Stoehr R; Bolderson E; Rehman I; Rosario DJ; Hamdy FC; Meuth M
    J Urol; 2006 Jun; 175(6):2323-30. PubMed ID: 16697867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epithelial membrane protein 2 is a prognostic indictor for patients with urothelial carcinoma of the upper urinary tract.
    Wang YW; Li WM; Wu WJ; Chai CY; Chang TY; Sun Y; Cheng CJ; Shiue YL; Su SJ; Cheng HL; Liu HS; Chow NH
    Am J Pathol; 2013 Sep; 183(3):709-19. PubMed ID: 23838430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.